Sexually Transmitted Diseases (STDs)

  • Anja Potthoff
  • Heinrich Rasokat
  • Norbert H. Brockmeyer

Key Features

  • The incidence of sexually transmitted infections is rising worldwide.

  • There is still no resistance of Treponema pal-lidum against penicillin.

  • There is a growing Neisseria gonorrhoeae resistance against chinolones and azithromycin.

  • Sexually transmitted diseases have to be considered in uncommon localizations (e.g., anal or oral lesions)

  • Patients presenting with a sexually transmitted infection should be screened for others including HIV


Ectopic Pregnancy Chlamydia Trachomatis Genital Herpes Chlamydia Infection Partner Notification 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    CDC (2003) Primary and secondary syphilis-United States 2003-2004. MMWR Morb Mortal Wkly Rep 55:269–273Google Scholar
  2. 2.
    Clark EG, Danbolt N (1955) The Oslo study of the natural history of untreated syphilis. An epidemiologic investigation based on a restudy of the Boeck-Brunsgaard material. J Chronic Dis 2:311–344PubMedCrossRefGoogle Scholar
  3. 3.
    Larsen SA, Steiner BM, Rudolph AH (1995) Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 8:1–21PubMedGoogle Scholar
  4. 4.
    CDC (2006) Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 55:1–94Google Scholar
  5. 5.
    Bracero L, Wormser GP, Bottone EJ (1979) Serologic tests for syphilis: a guide to interpretation in various states of disease. Mt Sinai J Med 46:289–292PubMedGoogle Scholar
  6. 6.
    Carey J (2003) Congenital syphilis in the 21st century. Curr Womens Health Rep 3:299–302PubMedGoogle Scholar
  7. 7.
    Ali L, Roos KL (2002) Antibacterial therapy of neurosyphilis, lack of impact of new therapies. CNS Drugs 16: 799–802PubMedCrossRefGoogle Scholar
  8. 8.
    Goh BT, Smith GW, Samarasinghe L et al (1984) Penicillin concentrations in serum and cerebrospinal fluid after intramuscular injection of aqueous procaine penicillin 0.6 MU with and without probenecid. Br J Vener Dis 60:371–373PubMedGoogle Scholar
  9. 9.
    Hall CS, Klausner JD, Bolan GA (2004) Managing syphilis in the HIV-infected patient. Curr Infect Dis Rep 6:72–81PubMedCrossRefGoogle Scholar
  10. 10.
    Ducas J, Robson HG (1981) Cerebrospinal fluid penicillin levels during therapy for latent syphilis. JAMA 246: 2583–2584PubMedCrossRefGoogle Scholar
  11. 11.
    Lukehart SA, Godornes C, Molini BJ, Sonnett P, Hopkins S, Mulcahy F, Engelman J, Mitchell SJ, Rompalo AM, Marra CM, Klausner JD (2004) Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 351:154–158PubMedCrossRefGoogle Scholar
  12. 12.
    Nau R, Prange HW, Muth P et al (1993) Passage of cefo-taxime and ceftriaxone into the cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 27:1518–1524CrossRefGoogle Scholar
  13. 13.
    Dowell ME, Ross PG, Musher DM et al (1992) Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 93:481–488PubMedCrossRefGoogle Scholar
  14. 14.
    Parkes R, Renton A, Meheus A, Laukamm-Josten U (2004) Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS 15:73–88PubMedCrossRefGoogle Scholar
  15. 15.
    Rompalo AM, Joesoef MR, O'Donnell JA, Augenbraun M, Brady W, Radolf JD, Johnson R, Rolfs RT (2001) Clinical manifestations of early syphilis by HIV-status and gender: results of the syphilis and HIV study. Sex Transm Dis 28:158–165PubMedCrossRefGoogle Scholar
  16. 16.
    Czelusta A, Yen Moore A, van der Straaten M, Carrasco D, Tyring SK (2000) An overview of sexually transmitted diseases Part 3. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol 3:409–432CrossRefGoogle Scholar
  17. 17.
    Morris SR, Klausner JD, Buchbinder SP et al (2006) Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis 43:1284–1289PubMedCrossRefGoogle Scholar
  18. 18.
    Farley TA, Cohen DA, Elkins W (2003) Asymptomatic sexually transmitted diseases: the case for screening. Prev Med 36:502–509PubMedCrossRefGoogle Scholar
  19. 19.
    Johnson RE, Newhall WJ, Papp JR et al (2002) Screening tests to detect Chlamydia trachomatis and Neisseria gonor-rhoeae infections 2002. MMWR Recomm Rep 51:1–27PubMedGoogle Scholar
  20. 20.
    Sutrisna A, Soebjakto O, Wignall FS et al (2006) Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004-implications for treatment. Int J STD AIDS 17:810–812PubMedCrossRefGoogle Scholar
  21. 21.
    Peeling RW, Holmes KK, Mabey D, Ronald A (2006) Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect 82(supl 5):v1–v6PubMedCrossRefGoogle Scholar
  22. 22.
    Lau C-Y, Qureshi AK (2002) Azithromycin versus doxycy-cline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transmit Dis 29:497–502CrossRefGoogle Scholar
  23. 23.
    Van de Laar MJ (2006) The emergence of LGV in Western Europe: what do we know, what can we do? Euro Surveill 20:11Google Scholar
  24. 24.
    Czelusta A et al (2000) An overview sexually transmitted diseases. Part II. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol 43:409–432PubMedCrossRefGoogle Scholar
  25. 25.
    Mabey D, Peeling RW (2002) Lymphogranuloma venereum. Sex Transm Infect 78:90–92PubMedCrossRefGoogle Scholar
  26. 26.
    Lewis DA (2003) Chancroid: clinical manifestations, diagnosis and management. Sex Transm Infect 79:68–71PubMedCrossRefGoogle Scholar
  27. 27.
    Steen R (2001) Eradicating chancroid. Bull World Health Organ 79:818–826PubMedGoogle Scholar
  28. 28.
    Kaur C et al (2002) Erythema nodosum induced by chancroid. Sex Transm Infect 78:388–389PubMedCrossRefGoogle Scholar
  29. 29.
    Morrone A et al (2003) Donovanosis in developed countries: neglected or misdiagnosed disease? Int J STD AIDS 14:288–289PubMedCrossRefGoogle Scholar
  30. 30.
    O'Farrell N (2002) Donovanosis. Sex Transm Infect 78:452–457PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Anja Potthoff
    • 1
  • Heinrich Rasokat
    • 2
  • Norbert H. Brockmeyer
    • 1
  1. 1.Department of Dermatology and AllergologyRuhr Unversity BochumBochumGermany
  2. 2.Department of DermatologyUniversity of CologneCologneGermany

Personalised recommendations